| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Biomarkers Definitions Working Group, AJ Atkinson Jr, WA Colburn, ... Clinical pharmacology & therapeutics 69 (3), 89-95, 2001 | 7659 | 2001 |
| The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex MA Fischl, DD Richman, MH Grieco, MS Gottlieb, PA Volberding, ... New England Journal of Medicine 317 (4), 185-191, 1987 | 3435 | 1987 |
| Chronic fatigue syndrome: a working case definition GP Holmes, JE Kaplan, NM Gantz, AL Komaroff, LB Schonberger, ... Annals of internal medicine 108 (3), 387-389, 1988 | 2601 | 1988 |
| A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter SM Hammer, DA Katzenstein, MD Hughes, H Gundacker, RT Schooley, ... New England Journal of Medicine 335 (15), 1081-1090, 1996 | 1423 | 1996 |
| Antiretroviral therapy in adults: updated recommendations of the International AIDS Society–USA Panel CCJ Carpenter, DA Cooper, MA Fischl, JM Gatell, BG Gazzard, ... Jama 283 (3), 381-390, 2000 | 1383 | 2000 |
| Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome DD Ho, TR Rota, RT Schooley, JC Kaplan, JD Allan, JE Groopman, ... New England Journal of Medicine 313 (24), 1493-1497, 1985 | 1342 | 1985 |
| Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel SM Hammer, JJ Eron, P Reiss, RT Schooley, MA Thompson, S Walmsley, ... Jama 300 (5), 555-570, 2008 | 1294 | 2008 |
| Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus RM Dedrick, CA Guerrero-Bustamante, RA Garlena, DA Russell, K Ford, ... Nature medicine 25 (5), 730-733, 2019 | 1208 | 2019 |
| Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection RT Schooley, B Biswas, JJ Gill, A Hernandez-Morales, J Lancaster, ... Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 00954-17, 2017 | 1192 | 2017 |
| Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010 | 1157 | 2010 |
| Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel SM Hammer, MS Saag, M Schechter, JSG Montaner, RT Schooley, ... Jama 296 (7), 827-843, 2006 | 1138 | 2006 |
| Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society—USA Panel CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ... Jama 277 (24), 1962-1969, 1997 | 1050 | 1997 |
| HIV-specific cytotoxic T lymphocytes in seropositive individuals BD Walker, S Chakrabarti, B Moss, TJ Paradis, T Flynn, AG Durno, ... Nature 328 (6128), 345-348, 1987 | 1050 | 1987 |
| Reducing transmission of SARS-CoV-2 KA Prather, CC Wang, RT Schooley Science 368 (6498), 1422-1424, 2020 | 1038 | 2020 |
| Vidarabine versus acyclovir therapy in herpes simplex encephalitis RJ Whitley, CA Alford, MS Hirsch, RT Schooley, JP Luby, FY Aoki, ... New England Journal of Medicine 314 (3), 144-149, 1986 | 1032 | 1986 |
| Ten scientific reasons in support of airborne transmission of SARS-CoV-2 T Greenhalgh, JL Jimenez, KA Prather, Z Tufekci, D Fisman, R Schooley The lancet 397 (10285), 1603-1605, 2021 | 1015 | 2021 |
| Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel PG Yeni, SM Hammer, CCJ Carpenter, DA Cooper, MA Fischl, JM Gatell, ... Jama 288 (2), 222-235, 2002 | 989 | 2002 |
| Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society–USA Panel CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ... Jama 280 (1), 78-86, 1998 | 906 | 1998 |
| Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 843 | 2015 |
| Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ... Jama 276 (2), 146-154, 1996 | 811 | 1996 |
